Simultaneous and two-stage approaches in patients with colorectal cancer and synchronous liver metastasis

Authors

  • Y. M. Grytsenko I. Horbachevsky Ternopil National Medical University
  • A. D. Bedeniuk I. Horbachevsky Ternopil National Medical University
  • S. Y. Grytsenko I. Horbachevsky Ternopil National Medical University

DOI:

https://doi.org/10.11603/2414-4533.2020.1.10610

Keywords:

synchronous liver metastasis of CRC, simultaneous operations, overall survival, disease-free survival

Abstract

The aim of the work: to analyze simultaneous and two-stage approaches in the treatment of patients with colorectal cancer and synchronous liver metastasis, as well as their overall and disease-free survival.

Materials and Methods. 16 patients (10 men and 6 women) patients with colorectal cancer and synchronous liver metastasis who underwent simultaneous (14) and two-stage (2) radical resections at Ternopil University Hospital from 2013 to 2018. All colorectal resections were performed in accordance with the requirements of oncological radicalism (D3 lymphodissection, total mesocolic/mesorectal excision). In 9 patients, liver metastasis were localized in the left lobe and in 7 patients – in the right lobe. Parenchymal-sparing technique for liver resection was used in 13 (81.3 %) patients, while anatomic resection of the liver was performed in 3 (18.8 %) patients. Adjuvant chemptherapy was given to all patients (6 courses of FOLFOX or XELOX).

Results and Discussion. We did not observe any severe postoperative complication or 30-day mortality. The median overall and disease-free survival in the group of patients with regional metastasis was (24.3±4.8) (p <0.013) and 13 months (p <0.020) respectively (all patients died between 4 and 44 months). All patients who had no regional lymph nodes metastasis are still alive without signs of progression. The longest overall survival period is 80 months and are observed at the time of writing of this article in 3 patients (follow-up period 11–80 months). The median overall and disease-free survival in the patients with right-sided CRC was 17.3 (p <0.51) and 9.2 months (p <0.51), respectively. Simultaneous CRC resection and parenchymal-sparing liver resection do not show an increase in the number of severe postoperative complications and 30-day mortality, which is also confirmed by our study.

References

Bartolini, I., Ringressi, M.N., Melli, F., Risaliti, M., Brugia, M., Mini, E., & Taddei, A. (2018). Analysis of prognostic factors for resected synchronous and metachronous liver metastases from colorectal cancer. Gastroenterology Research and Practise, 11, 7. DOI: https://doi.org/10.1155/2018/5353727

Creasy, J.M., Sadot, E., Koerkamp, B.G., Chou, J.F., Go­nen, M., Kemeny, N.E., …, & D'Angelica, M.I. (2018). Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? Surgery, 163, 6, 1238-1244. DOI: https://doi.org/10.1016/j.surg.2018.01.004

Donadon, M., Cescon, M., Cucchetti, A., Cimino, M., Costa, G., Pesi, B., ..., & Torzilli, G. (2017). Parenchymal sparing surgery for the surgical treatment of multiple colorectal liver metastases is a safer approach than major hepatectomy not impairing patients’ prognosis: a bi-institutional propensity score-matched analysis. Digestive Surgery, 35 (4), 342-349.

Engstrand, J., Nilsson, H., Strömberg, C., Jonas, E., & Freedman, J. (2018). Colorectal cancer liver metastases – a population-based study on incidence, management and survival. BMC Cancer, 18, 1, 78. DOI: https://doi.org/10.1186/s12885-017-3925-x

Gavriilidis, P., Katsanos, K., Sutcliffe, R.P., Simopoulos, C., Azoulay, D., & Roberts, K.J. (2018). Simultaneous versus delayed hepatectomy for synchronous colorectal liver metastases: a systematic review and meta-analysis. HPB, 20 (1), 11-19. DOI: https://doi.org/10.1016/j.hpb.2017.08.008

Mise, Y., Aloia, T.A., Brudvik, K.W., Schwarz, L., Vauthey, J.N., & Conrad, C. (2016). Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival. Annals of Surgery, 263 (1), 146-152. DOI: https://doi.org/10.1097/SLA.0000000000001194

Nordlinger, B., Sorbye, H., Glimelius, B., Poston, G.J., Schlag, P.M., Rougier, P., …, & Gruenberger, T. (2013). Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. The Lancet Oncology, 14, 12, 1208-1215. DOI: https://doi.org/10.1016/S1470-2045(13)70447-9

Ono, Y., Saiura, A., Arita, J., Takahashi, Y., Takahashi, M., & Inoue, Y. (2017). Short-term outcomes after simultaneous colorectal and major hepatic resection for synchronous colorectal liver metastases. Digestive Surgery, 34 (6), 447-454. DOI: https://doi.org/10.1159/000455295

Vallance, A.E., van der Meulen, J., Kuryba, A., Charman, S.C., Botterill, I.D., Prasad, K.R., …, & Walker, K. (2018). The timing of liver resection in patients with colorectal cancer and synchronous liver metastases: a population-based study of current practice and survival. Colorectal Disease, 20 (6), 486-495. DOI: https://doi.org/10.1111/codi.14019

Yahagi, M., Okabayashi, K., Hasegawa, H., Tsuruta, M., & Kitagawa, Y. (2016). The worse prognosis of right-sided compared with left-sided colon cancers: a systematic review and metaanalysis. Journal of Gastrointestinal Surgery, 20 (3), 648-655. DOI: https://doi.org/10.1007/s11605-015-3026-6

Published

2020-01-15

Issue

Section

Experience of work

How to Cite

Simultaneous and two-stage approaches in patients with colorectal cancer and synchronous liver metastasis. (2020). Hospital Surgery. Journal Named by L.Ya. Kovalchuk, 1, 119-124. https://doi.org/10.11603/2414-4533.2020.1.10610